1. Upper GI Cancer Research Report Site Specific Group Meeting Friday 29th January 2016

2. Cancer specialty specific objectives
Recruitment overall at 20% of cancer incidence
Recruitment to interventional studies at 7.5% of cancer incidence
Recruiting local portfolio to include:
Surgical trials (4 recruits per 100,000 pop)
Rare cancers (12 recruits per 100,000 pop)
Children and young people (3 recruits per 100,000 pop)
Radiotherapy (6 recruits per 100,000 pop)

3. Studies recruiting

5. New studies in set up pending NHS permission for consideration locally
SCALOP-2 - A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/-nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer. Closure date: November 2019
ACTICCA-­1 - Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA­-1 trial) A randomized, multidisciplinary, multinational AIO/DGAV/DGVS phase III trial Closure date: August 2018

6. Contact maxine.taylor@nihr.ac.uk
UGI SSG and CRN: West of England Research Lead
Contact

7. Contact & reference details
– Research Delivery Manager
– Network Cancer Clinical Lead
- for detailed list of whole UGI portfolio including links to eligibility criteria